Scholar Rock Holding Corp (NAS:SRRK)
$ 9.43 -0.4 (-4.07%) Market Cap: 752.08 Mil Enterprise Value: 605.68 Mil PE Ratio: 0 PB Ratio: 4.12 GF Score: 55/100

Scholar Rock Holding Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 06:00PM GMT
Release Date Price: $17.47 (+2.76%)
Jason Russell;Morgan Stanley;Executive Director
Healthcare Investment Banking,

Good afternoon, everyone. My name is Jason Russell with the Morgan Stanley Healthcare Investment Banking team. Welcome. I'm joined today with -- by Tony Kingsley, President and CEO of Scholar Rock Therapeutics; as well as Yung Chyung, Scholar Rock's Chief Medical Officer; and Ted Myles, the company's CFO.

Before we jump into the discussion this afternoon, I should cover a quick disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot